|
Delayed
Toronto S.E.
08:11:42 19/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 9.650 CAD | +4.32% |
|
-2.53% | +21.84% |
| 05/10 | Satellos Bioscience Granted Composition of Matter Patent for Forazapadin by USPTO | MT |
| 05/10 | Satellos Bioscience Receives US Patent for Forazapadin | MT |
Chart: Technical Analysis
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| MSCL | Delayed | |
Nasdaq
| MSLE | Delayed | |
|
CBOE
| MSLE | Real-time | |
|
Deutsche Boerse AG
| 0IT | Delayed | |
|
Tradegate
| 0IT | Real-time | |
|
Börse Stuttgart
| 0IT | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 11.13 | 14.38 | 17.01 |
| Spread/Res. | -13.30% | -32.89% | -43.27% |
| Spread/Supp. | +22.31% | +22.31% | +20.32% |
| Support | 7.89 | 7.89 | 8.02 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MSCL Stock
- Charts Satellos Bioscience Inc.
Select your edition
All financial news and data tailored to specific country editions
